These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Determination of differentially regulated proteins upon proteasome inhibition in AML cell lines by the combination of large-scale and targeted quantitative proteomics. Matondo M; Marcellin M; Chaoui K; Bousquet-Dubouch MP; Gonzalez-de-Peredo A; Monsarrat B; Burlet-Schiltz O Proteomics; 2017 Apr; 17(7):. PubMed ID: 27709814 [TBL] [Abstract][Full Text] [Related]
10. Small-molecule RA-9 inhibits proteasome-associated DUBs and ovarian cancer in vitro and in vivo via exacerbating unfolded protein responses. Coughlin K; Anchoori R; Iizuka Y; Meints J; MacNeill L; Vogel RI; Orlowski RZ; Lee MK; Roden RB; Bazzaro M Clin Cancer Res; 2014 Jun; 20(12):3174-86. PubMed ID: 24727327 [TBL] [Abstract][Full Text] [Related]
11. Proteasome inhibitors abolish cell death downstream of caspase activation during anti-microtubule drug-induced apoptosis in leukemia cells. Nagy K; Petak I; Imre G; Barna G; Gezane-Csorba M; Sebestyen A; Houghton JA; Mihalik R; Kopper L Anticancer Res; 2005; 25(5):3321-6. PubMed ID: 16101145 [TBL] [Abstract][Full Text] [Related]
12. Proteasome inhibition induces both pro- and anti-cell death pathways in prostate cancer cells. Yang W; Monroe J; Zhang Y; George D; Bremer E; Li H Cancer Lett; 2006 Nov; 243(2):217-27. PubMed ID: 16413676 [TBL] [Abstract][Full Text] [Related]
13. Selective activation of TNFR1 and NF-κB inhibition by a novel biyouyanagin analogue promotes apoptosis in acute leukemia cells. Savva CG; Totokotsopoulos S; Nicolaou KC; Neophytou CM; Constantinou AI BMC Cancer; 2016 Apr; 16():279. PubMed ID: 27098354 [TBL] [Abstract][Full Text] [Related]
14. The proton pump inhibitor pantoprazole disrupts protein degradation systems and sensitizes cancer cells to death under various stresses. Cao Y; Chen M; Tang D; Yan H; Ding X; Zhou F; Zhang M; Xu G; Zhang W; Zhang S; Zhuge Y; Wang L; Zou X Cell Death Dis; 2018 May; 9(6):604. PubMed ID: 29789637 [TBL] [Abstract][Full Text] [Related]
15. Anticancer activity of cryptotanshinone on acute lymphoblastic leukemia cells. Wu CF; Klauck SM; Efferth T Arch Toxicol; 2016 Sep; 90(9):2275-2286. PubMed ID: 26564229 [TBL] [Abstract][Full Text] [Related]
16. LukS-PV induces mitochondrial-mediated apoptosis and G0/G1 cell cycle arrest in human acute myeloid leukemia THP-1 cells. Bu S; Xie Q; Chang W; Huo X; Chen F; Ma X Int J Biochem Cell Biol; 2013 Aug; 45(8):1531-7. PubMed ID: 23702031 [TBL] [Abstract][Full Text] [Related]
17. Increased expression and altered subunit composition of proteasomes induced by continuous proteasome inhibition establish apoptosis resistance and hyperproliferation of Burkitt lymphoma cells. Fuchs D; Berges C; Opelz G; Daniel V; Naujokat C J Cell Biochem; 2008 Jan; 103(1):270-83. PubMed ID: 17516511 [TBL] [Abstract][Full Text] [Related]
18. The role of the ubiquitin proteasome system in lymphoma. Suh KS; Tanaka T; Sarojini S; Nightingale G; Gharbaran R; Pecora A; Goy A Crit Rev Oncol Hematol; 2013 Sep; 87(3):306-22. PubMed ID: 23541070 [TBL] [Abstract][Full Text] [Related]
19. Elevation of proteasomal substrate levels sensitizes cells to apoptosis induced by inhibition of proteasomal deubiquitinases. Sun C; Roboti P; Puumalainen MR; Fryknäs M; Wang X; D'Arcy P; Hult M; High S; Linder S; Swanton E PLoS One; 2014; 9(10):e108839. PubMed ID: 25286379 [TBL] [Abstract][Full Text] [Related]
20. New insights into the molecular mechanisms underlying sensitivity/resistance to the atypical retinoid ST1926 in acute myeloid leukaemia cells: the role of histone H2A.Z, cAMP-dependent protein kinase A and the proteasome. Fratelli M; Fisher JN; Paroni G; Di Francesco AM; Pierri F; Pisano C; Godl K; Marx S; Tebbe A; Valli C; Gianni M; Stravalaci M; Gobbi M; Terao M; Garattini E Eur J Cancer; 2013 Apr; 49(6):1491-500. PubMed ID: 23245330 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]